Raising HDL cholesterol in women
نویسندگان
چکیده
High-density lipoprotein cholesterol (HDL-C) concentration is essential in the determination of coronary heart disease (CHD) risk in women. This is especially true in the postmenopausal state, where lipid profiles and CHD risk mimic that of age-matched men. Thus, interventions designed to reduce CHD risk by raising HDL-C levels may have particular significance during the transition to menopause. This review discusses HDL-C-raising therapies and the role of HDL in the primary prevention of CHD in women. Lifestyle-based interventions such as dietary change, aerobic exercise regimens, and smoking cessation are initial steps that are effective in raising HDL-C, and available data suggest women respond similarly to men with these interventions. When combined with pharmacotherapy, the effects of these lifestyle alterations are further amplified. Though studies demonstrating gender-specific differences in therapy are limited, niacin continues to be the most effective agent in raising HDL-C levels, especially when used in combination with fibrate or statin therapy. Emerging treatments such as HDL mimetic therapy show much promise in further raising HDL-C levels and improving cardiovascular outcomes.
منابع مشابه
Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction.
OBJECTIVE Patients with diabetes remain at high risk for cardiovascular events despite aggressive blood pressure, LDL cholesterol, and blood glucose control. We identified prevalence and predictors of low HDL cholesterol, characterized current lipid therapy, and estimated the theoretical benefit of more effective HDL cholesterol-raising methods among patients with type 2 diabetes. RESEARCH DE...
متن کاملLipid-altering drugs: decreasing cardiovascular disease at the expense of increasing cancer?
To the Editor: The interesting paper by Cao et al. (1) exposes a disturbing paradox in preventive medicine that has significant implications. They demonstrated that expression of a mutant receptor for high-density lipoprotein (HDL) on breast cancer cell line MCF-7 inhibited the proliferation and attenuated the antiapoptotic effect of HDL on the breast cancer cells. This supports previous data s...
متن کاملLipid-Altering Drugs: Decreasing Cardiovascular Disease at the Expense of Increasing Cancer?
To the Editor: The interesting paper by Cao et al. (1) exposes a disturbing paradox in preventive medicine that has significant implications. They demonstrated that expression of a mutant receptor for high-density lipoprotein (HDL) on breast cancer cell line MCF-7 inhibited the proliferation and attenuated the antiapoptotic effect of HDL on the breast cancer cells. This supports previous data s...
متن کاملHigh density lipoprotein - should we raise it?
Low high-density lipoprotein (HDL) cholesterol levels are associated with an increased risk of coronary artery disease and myocardial infarction. Experimental studies have identified several potential anti-atherogenic properties of HDL, including promotion of macrophage cholesterol efflux, endothelial nitric oxide stimulation, anti-inflammatory and anti-thrombotic effects. These observations ha...
متن کاملAdipose modulation of high-density lipoprotein cholesterol: implications for obesity, high-density lipoprotein metabolism, and cardiovascular disease.
High-density lipoprotein-cholesterol (HDL-C) levels inversely correlate with atherosclerotic cardiovascular disease (CVD).1 HDL plays a key role in reverse cholesterol transport by promoting cholesterol efflux from peripheral cells, including cholesterol-laden macrophages, and delivering acquired cholesterol to liver for excretion, a process that is believed to be atheroprotective.2 However, wh...
متن کامل